Deep search
Search
Images
Copilot
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
11m
Why a common asthma drug will now carry extra safety warnings about depression
The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...
DublinLive
41m
Dublin City Council introducing 'light boxes' to help combat Seasonal Affective Disorder
The devices have been proven to lift people’s moods, boost alertness and help those who use them feel more energised ...
Hosted on MSN
49m
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Waltz resigns from House
Coast Guard chief fired
Silk Road founder pardoned
'Days of Our Lives' star dies
Released from prison
SCOTUS grants new hearing
Birthright citizenship suit
Doug Collins hearing
NC Rep. Joe John resigns
Set to leave DOGE
Former prosecutor faces trial
Judge blocks report release
Milley's portrait taken down
Taliban frees 2 Americans
Elise Stefanik testifies
Agent fatally shot in VT
Fire at ski resort in Turkey
National championship win
Acting defense secretary
Gulf Coast winter storm
CBP One app shut down
Trailblazing cartoonist dies
Israel’s top general resigns
Discuss strengthening ties
To host '25 Grammy Awards
Raising prices again
FDA approves nasal spray
Antisemitism lawsuits settled
Djokovic beats Alcaraz
Can target schools, churches
1st Japanese elected to HOF
Related topics
United States
Blue Monday
Johnson & Johnson
Spravato
Food and Drug Administration
Feedback